Prof. Dr. Dimitrios Mougiakakos
Department of Hematology and Oncology
Prof. Dr. Verena Keitel-Anselmino
Department of Gastroenterology, Hepatology und Infectiology
Prof. Dr. Peter Mertens
Department of Nephrology, Diabetology and Endocrinology
Here you can find current announcements, newspaper articles, press statements, radio and TV segments and more about the GC-I³.
Prof. Dr. med. habil. Stephan Fricke, Director of our Institute for Clinical Immunology and Cell Therapeutics (IKIZ), was unanimously elected spokesperson of the Health Campus Immunology, Infectiology and Inflammation (GC-I³) on 10 September 2026. He combines clinical expertise in immunology, haematology and oncology with the development of cell and gene therapies and their translation into clinical practice.
Professor Fricke has held the W3 Professorship in Clinical Immunology and Cell Therapeutics at University Medicine Magdeburg since October 2025. Previously, he served as Executive Senior Physician at Chemnitz Hospital. With certification as a specialist immunologist from the German Society for Immunology and an additional medical qualification in immunology, he brings together the treatment of cancer and immune disorders with applied research. He also serves as Director of Clinical Translation at the Fraunhofer Institute for Cell Therapy and Immunology IZI, where he has worked since 2006.
A key focus of his work is translating experimental manufacturing processes into GMP-compliant procedures for advanced therapy medicinal products (ATMPs), including CAR T-cell therapeutics. This work addresses a critical step between laboratory development and clinical investigation. Further research aims include developing cellular therapies for autoimmune diseases and reducing severe immune complications following cell transplantation.
This combination of patient care, immunological research and pharmaceutical process development shapes the expertise he brings to his role as spokesperson. The GC-I³ provides an interdisciplinary framework for connecting findings on immune regulation, infection and inflammation with clinical research questions.
We warmly congratulate Professor Fricke on his election and wish him every success in his new role.
In 2023 the Health Campus Immunology, Infectiology and Inflammation is again calling for submissions for the "GC-I³ Paper of the year". Please apply until the 31st of January 2024. We are going to award three prizes (worth 1000 €, 500 € and 250 €, respectively) and we are looking forward to your applications!
Am 27. April 2023 fand das 3. Nachwuchssymposium des Gesundheitscampus Immunologie, Infektiologie und Inflammation statt, bei dem die drei Gewinner des „GC-I³ Paper des Jahres 2022“ ermittelt wurden.
In 2021 the Health Campus Immunology, Infectiology and Inflammation is again calling for submissions for the "GC-I³ Paper of the year". Please apply until the 31st of January 2022. We are going to award three prizes (worth 1000 €, 500 € and 250 €, respectively) and we are looking forward to your applications!
Nachdem die Nachwuchswissenschaftler:innen des GC-I³ zum sechsten Mal aufgerufen waren, sich um das Paper des Jahres zu bewerben, hatten die Mitglieder die schwere Aufgabe unter insgesamt 12 Bewerbungen mit einem durchschnittlichen Impact Factor von 8,4 die drei besten auszuwählen.
In 2021 the Health Campus Immunology, Infectiology and Inflammation is again calling for submissions for the "GC-I³ Paper of the year". Please apply until the 31st of January 2022. We are going to award three prizes (worth 1000 €, 500 € and 250 €, respectively) and we are looking forward to your applications!
Im Rahmen seines 1. Nachwuchssymposiums zeichnete der Gesundheitscampus Immunologie, Infektiologie und Inflammation am 14. Juli die „GC-I³ Paper des Jahres 2020“ aus. Bereits zum fünften Mal hatte der GC-I³ im Jahr 2020 seine Mitglieder aufgerufen, sich um das Paper des Jahres zu bewerben. Unter insgesamt 15 Bewerbungen mit einem durchschnittlichen Impact Factor von 7,9 wurden nun die besten drei ausgewählt.
The Else Kröner-Fresenius foundation supports highly qualified young clinicians who, in addition to their daily clinical work, want to dedicate themselves to the demanding task of research. The thematic focus of the EKFK Magdeburg has recently been expanded. Under the title “Cancer and tissue-destroying inflammation – the role of the inflammatory microenvironment”, the college will continue to provide research time for young physicians over the next two years.
A team of GC-I³ scientists at the Institute for Molecular and Clinical Immunology unravels a crucial mechanism of cell-cell-communication during the defense against pathogens.
The SFB 854 welcomes applications for seed funding from young investigators. The objective of this award is to provide salary or non-salary funds for young investigators and clinician scientists to help establish their research careers. The intent of this award is to stimulate research in line with the objectives of the GC-I³.
Prof. Dr. Dimitrios Mougiakakos
Department of Hematology and Oncology
Prof. Dr. Verena Keitel-Anselmino
Department of Gastroenterology, Hepatology und Infectiology
Prof. Dr. Peter Mertens
Department of Nephrology, Diabetology and Endocrinology
Dr. rer. nat. Martina Beyrau
Press and Public Relations Officer of SFB 854 & GC-I³
Institute of Molecular and Clinical Immunology
Leipziger Straße 44, House 26
39120 Magdeburg
E-mail: martina.beyrau@med.ovgu.de
Last Modification: 29.10.2026 - Contact Person: